Compare Moderna, Inc. (MRNA) vs Navitas Semiconductor Corporation Common Stock (NVTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Navitas Semiconductor Corporation Common Stock — how do they compare? Moderna, Inc. trades at $225 (market cap $78.65B), while Navitas Semiconductor Corporation Common Stock trades at $10.78 (market cap $2.87B). The key difference: Moderna, Inc. is far larger — about 27.4× Navitas Semiconductor Corporation Common Stock's market cap, and Moderna, Inc. is trading nearer its 52-week high, Navitas Semiconductor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Navitas Semiconductor Corporation Common Stock for 0 Days on average.
| MRNA | NVTS | |
|---|---|---|
Market Cap | $78.65B | $2.87B |
Volume | 37,373,437 | 13,752,519 |
Sector | Health | Technology |
52-Week High | $203.46 | $31.79 |
52-Week Low | $22.36 | $7.14 |
Typical Hold Time | 59 Days | 0 Days |
Enterprise Value | $74.80B | $2.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $197.00, up 0.26% on the day, with technical indicators showing a bullish trend and strong momentum. The stock has rallied over 500% in 2026, driven by positive clinical updates for its cancer vaccine pipeline and inclusion in the Nasdaq-100 index effective October 9, 2026. However, fundamentals remain challenging with revenue declining from $18.9B in 2022 to $1.9B in 2025 and negative net income margins exceeding 140%.
While technical momentum and pipeline optimism support near-term upside, valuation appears stretched with P/S of 35.08 and negative profitability metrics. Key risks include execution on non-COVID products, competitive pressure, and sustainability of recent gains. Analyst consensus is cautious with only 28% buy ratings and $115.70 price target suggesting significant downside from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Navitas Semiconductor Corporation Common Stock
Navitas Semiconductor designs and markets gallium nitride and silicon carbide power semiconductors. Its products are used in power conversion and charging for data centers, energy infrastructure, and industrial applications.
Read more on NVTS →
